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Effect of Hydroxyzine and Meperidine
on Arterial Blood Gases in Healthy
Human Volunteers
Elemer K. Zsigmond, MD, FCP, Kathleen Flynn, and John G. Shively, MD
Because hydroxyzine hydrochloride is frequently used to tranquilize patients, who are
receiving narcotic analgesics for pain relief, its effect alone and in combination with
meperidine on arterial blood gases and ventilation in patients at rest was evaluated in 65
healthy volunteers, who gave informed consent. Hydroxyzine hydrochloride, 1.5 mg/kg
IV given over 30 seconds, caused no decrease but rather a significant (P < .001) increase
in Pao2 and no increase in Paco2 and/or pH at 5, 10, 20, 30, and 60 minutes (N = 29;
mean age = 47.0 years). Meperidine, 1.5 mg/kg IV given over 30 seconds, caused a
significant (P <.01) reduction in Pao2 at 5 minutes indicating ventilatory depression but
no increase in Paco2 and/or pH (N = 19; mean age = 32.4 years). The combination of the
same doses of hydroxyzine with meperidine IV caused a significantly greater decrease in
Pao2 only at 10 minutes but a greater increase in Paco2 and pH at all times for 60 minutes
than did meperidine alone (N = 17; mean age = 39.5 years), which indicates greater
ventilatory depression with the combination than with hydroxyzine alone. However,
Pao2, Paco2 and pH remained within the awake normal ranges for Pao2, Paco2, and pH
for the age group of volunteers even at 10 minutes after IV injection of the drug combina-
tion when most of the volunteers were asleep. In conclusion, hydroxyzine even when
given IV in excess of the maximum IM therapeutic doses caused no changes in Pao2,
Paco2 or pH, which would indicate clinically important ventilatory depression. Further-
more, blood gases remained in the normal awake range even after the combined IV
administration of hydroxyzine and meperidine in excess of the maximum IM therapeutic
doses.
T ranquilizers are used commonly to reduce anxi-
ety and restlessness in psychiatric, critically ill,
cardiac, and surgical patients and for ataract analge-
sia, an anesthetic technique based on the combined
IV administration of tranquilizers and narcotic an-
algesics. Hence, it is essential to know if and to what
extent a particular tranquilizer and/or narcotic an-
algesic alters blood gases and, consequently, venti-
lation. Narcotics are also frequently used as prean-
esthetic medications in surgical patients, especially
in those who have pain before surgery. Some even
believe that narcotic analgesics create a state of eu-
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phoria and relaxation thereby alleviating fear and/
or anxiety. Because of the clinically important yen-
tilatory depression caused by narcotic analgesics, we
only use them if the patient requires them for pain
relief. For tranquilization, we use tranquilizers that
have specific action on the limbic system, for exam-
ple, hydroxyzine, to allay apprehension before sur-
gery and/or anesthesia,1 because a previous double-
blind study showed that hydroxyzine effectively re-
lieved anxiety.2 To substantiate earlier reports on
the lack of ventilatory depressant effects by hy-
droxyzine,3’4 our clinical pharmacologic studies on
arterial blood gases after IV hydroxyzine in healthy
volunteers was undertaken.
The combination of tranquilizers and narcotic an-
algesics has been used frequently (IM or IV) to allevi-
ate preoperative anxiety, fear and/or pain in surgi-
cal patients, and even in combination with barbitu-
rates. Dangerous arterial hypoxemia, however, was
observed after the combined IM use of narcotics,
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phenothiazines, and barbiturates in cardiac patients
by Pierce and Garofalvo.5 This observation was not
unexpected, because severe ventilatory depression
associated with the use of narcotic analgesics has
been well substantiated.6 Although ample studies
were carried out on changes of respiratory center
CO2 sensitivity to meperidine and hydroxyzine,49
no blood gas studies were as yet carried out either
with tranquilizers alone, narcotic analgesics alone,
or with combination of these drugs either in healthy
humans or patients with pulmonary or cardiovascu-
lar diseases. Because blood gas determinations are
used frequently in the evaluation of patients and of
ventilatory adequacy, the information derived from
our studies may facilitate the correct monitoring of
patients, especially in the postoperative recovery
room or intensive care units.
To determine the effect of drugs in combination,
first each component should be studied separately in
healthy humans and, furthermore, in patients with
pulmonary or cardiovascular diseases. Therefore,
hydroxyzine and meperidine were given alone and
in combination IV to healthy volunteers with nor-
mal pulmonary function and no evidence of cardiac
disease. The IV route was chosen for drug adminis-
tration for two reasons: (1) IV administration more
reliably achieves consistent and reproducible blood
levels (and thereby the drug effect) than does IM
administration, and (2) the peak blood levels after IV
administration far exceed those expected and ob-
served after IM administration, which is the most
commonly used route of administration for both
drugs. Consequently, if no respiratory depression
results from IV administration of a tranquilizer or
narcotic analgesic, the IM injection is not likely to
lead to respiratory depression. Therefore, these
clinical pharmacologic studies after IV administra-
tion of hydroxyzine and meperidine alone and in
combination were undertaken in healthy volunteers
and in patients with lung disease. The results of the
latter study will be reported later.
METHODS
Sixty-five healthy volunteers, who signed a valid
written consent and who were not undergoing drug
treatment or who were not habituated to any drug,
were selected for the study. The study was approved
by the institutional review board. No minors or preg-
nant women were accepted. Of these patients, 29
volunteers with a mean age 47.0 years (range, 18 to
84 years) received hydroxyzine 1.5 mg/kg IV over 30
seconds, 19 volunteers with a mean age of 32.4 years
(range, 19 to 62 years) received meperidine 1.5
mg/kg, and 17 volunteers with a mean age of 39.5
years (range, 19 to 70 years) received first hydroxy-
zine 1.5 mg/kg IV over 30 seconds followed 2 min-
utes later by meperidine 1.5 mg/kg IV over 30 sec-
onds. In a special research unit, the volunteers were
allowed to read or watch television unless they
spontaneously fell asleep, which commonly oc-
curred after the combination of hydroxyzine with
meperidine or either drug alone. They were main-
tained in the supine position throughout the study.
After a 20-G Riley arterial needle was inserted
into the brachial artery of the nonpreferred arm and
an IV infusion of 5% glucose in 0.2% saline solution
was started in the preferred arm, a period of rest was
allowed. Two baseline arterial blood samples were
then drawn at 20-minute intervals. If the two deter-
minations differed less than 5%, the study was
begun.
For monitoring respiratory rate, a chest plethys-
mograph was attached, and a continuous recording
was obtained on a Gilson polygraph. The brachial
arterial blood pressure through a Statham strain
gauge, lead II electrocardiogram, and phonocardio-
gram from the apex of the heart were also recorded
on a Gilson polygraph, at least up to 1 hour after the
last blood-gas sample to rule out adverse circulatory
changes that might have altered blood gases.
After the first two baseline samples were ob-
tained, each volunteer received the IV medication
injected slowly over 30 seconds.
The oxygen tension was directly determined with
a Clark oxygen electrode and the carbon dioxide
tension by the method of Siggaard-Anderson on a
Radiometer Copenhagen pH blood gas analyzer or
on an Instrumentation Laboratory H-113 pH blood
gas analyzer twice before and at 5, 10, 20, 30, and 60
minutes after drug administration. The pH was di-
rectly measured with the glass electrode of the pH
blood gas analyzer at the same time intervals.
Student’s t tests were used for statistical analysis
of the data.
RESULTS
Hydroxyzine caused no reduction but, rather, a
highly significant (P < .001) increase in Pao2 for 30
minutes after its administration (Table I). A decrease
in Paco2 and no change in pH was observed at any
time after its administration (Tables II and III). Me-
peridine caused a significant (P < .01) reduction in
Pao2 at 5 minutes (Figure) but no increase in Paco2
and/or pH (Tables II and III). The combination of
hydroxyzine with meperidine compared with me-
peridine alone caused a significant (P < .01) greater
decrease in Pao2 which peaked at 5 minutes and was
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TABLE I
Pao2 In Healthy Volunteers GIven Hydroxyzlne and Meperldine Alone and Their CombInatIon
Mean ± SD Pao2 In mm Hg
DrugsNo. 0 mln 5 mln 10 mm 20 mln 30 mln 60 mm
Hydroxyzine
(1.5 mg/kg) 29 82.4 ± 8.1 86.9 ± 7.2* 90.5 ± 4.8*** 89.4 ± 5.8*** 93.4 ± 54*** 78.4 ± 57*
Meperidine
(1.5 mg/kg) 19 85.3 ± 9.5 73.8 ± 95** 80.6 ± 11.1 83.9 ± 8.8 82.3 ± 9.3 83.8 ± 10.9
Hydroxyzine
(1.5 mg/kg)
and
meperidine
(1.5 mg/kg) 17 82.5 ± 9.0 70.0 ± 13.6cc 71.4 ± 8.9**tt 79.4 ± 8.5 79.5 ± 10.4 76.1 ± 9.2*t
* P < .05 as compared with 0 minute value. t P < .05 as compared with the meperidine group.
P < .01 as compared with 0 minute value. if P < .01 as compared with the meperidine group.
P < .001 as compared with 0 minute value. fff P < .001 as compared with the meperidine group.
sustained until 20 minutes (Table I). Until 20 min-
utes, the respiratory depression caused by the com-
bination was significantly greater than that caused
by meperidine (Figure). The increase in Paco2 and
pH compared with the baseline after the administra-
tion of the combination was highly significant (P
<.001) at 10 and 20 minutes but remained elevated
until 30 and 60 minutes, respectively (P < .05)
(Tables II and III, Figure). Until 20 minutes, the
Paco2 was significantly higher and the pH lower in
the hydroxyzine-meperidine than in the meperidine
group when the two groups were compared.
DISCUSSION
This is the first objective evaluation of blood gas
changes following hydroxyzine hydrochloride that
corroborated the previous reports34’71#{176} that hy-
droxyzine hydrochloride causes no ventilatory de-
pression in healthy humans in tranquilizing doses
even when given IV rather than IM or orally in doses
far in excess of doses considered optimal and safe in
clinical practice. Hydroxyzine causes an increase
rather than a decrease in Pao2, which is probably an
expression of a lower metabolic rate and thereby
lowered oxygen demand induced by tranquilization
and sleep in most of the volunteers. This lack of
decrease in Pao2 and increase in PaCO2 and/or pH
confirms the results of Lauria et al.7 and of our pre-
vious double-blind study, that minute ventilation,
respiratory rate, tidal volume, and CO2 response in
healthy volunteers were not altered by hydroxyzine
1.5 mg/kg IM.71#{176}Moreover, based on blood gas
values, the lack of clinically important additive or
potentiating effect of hydroxyzine on the ventilatory
depression caused by meperidine makes it a safe
tranquilizer for IM administration (note: hydroxy-
zine is not available for IV administration) to allay
apprehension in patients in pain receiving meperi-
dine IM, because the significant but modest decrease
in Pao2 and increase in Paco2 and pH with the IV
combination did not exceed the normal range of
values (Figure) for the age group of volunteers stud-
ied. Nor did the blood gas changes exceed the ranges
observed in sleeping healthy individuals1112 in any
of the volunteers who received hydroxyzine with
meperidine in combination. Of the 17 volunteers in
this group, 15 fell asleep shortly after IV injection
and slept for several hours but remained arousable
by loud questions. Two volunteers required skin
stimulation to be awakened in the first 20 minutes.
Seldom, if ever, will such large IV doses be required
except for surgical anesthesia. In routine clinical
practice, hydroxyzine is administered IM or P0 and
meperidine IM and in lower optimal effective doses
(50 mg), especially when combined. For our experi-
ments for the determination of possible potentiation
by hydroxyzine of the respiratory depression caused
by meperidine, we did the following: (1) We selected
the most reliable route of administration to achieve
predictable blood levels, i.e., the IV route. (2) A suf-
ficiently large IV dose (1.5 mg/kg) of meperidine was
used, causing predictable and marked respiratory
depression. (3) Doses of both drugs (1.5 mg/kg) were
given; the amounts are unlikely to be exceeded even
when given IM in clinical practice. We must em-
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Figure. Arterial blood gas changes after IV administration of 1.5mg/kg hydroxyzine, 1.5 mg/kg meperidine, and their combination. Upper
lines represent Pao2 and lower lines represent Paco2 (for statistical significance, see Tables).
phasize that we selected these large doses (1.5
mg/kg) only for the provocation of a potentiation of
the meperidine-induced ventilatory depression by
hydroxyzine in an experimental setting, and we do
not recommend the IM use of these large doses,
especially in combination, in clinical practice. Be-
cause hydroxyzine markedly potentiates analgesia,
a 50 mg IM dose is sufficient to produce optimal
effect.13
Since the completion of our study, no further stud-
ies on the effect of hydroxyzine and its combination
with meperidine on arterial blood gases have been
published. However, a few studies using a limited
number of volunteers (three to five) were reported
on the effect of hydroxyzine on the intercept and
slope of respiratory response curve to CO2 with a
refined, computerized method.14 In two of these
studies, a detectable right shift in the CO2 response
curve was observed, but the changes in the end-tidal
CO2 pressure curve was less than 1.0 mm Hg-0.84
mm Hg after 75 mg hydroxyzine IM and 0.96 mm Hg
after 100 mg hydroxyzine IV.89 However, some of
the volunteers (2 out of 5) developed respiratory
stimulation rather than depression in these studies.
By the same refined assay, the right shift in CO2
response curve was quantitated as comparable to 4
mg morphine IV in healthy volunteers.15 Conse-
quently, the authors concluded that the mild respi-
ratory depression following hydroxyzine adminis-
tration is of little clinical importance.9 Furthermore,
the limited number of studied subjects limited the
calculation of the significance of the findings of
changes in slope and intercept.8 It is conceivable that
the shift in CO2 response curves reported could be
due to the reduction of sensory input to the respira-
tory center by the depression of the limbic system by
hydroxyzine, although it is unclear from the reports
how many of the volunteers fell asleep after hy-
droxyzine administration. In our investigation, 86%
of the volunteers fell asleep and stayed asleep
throughout the study period of 2 to 3 hours. It has
been shown repeatedly that sleep per se reduces
Pao2 and increases Paco2 by 7 to 8 mm Hg because of
the reduction of the sensory input into the respira-
35.3 ± 2.6
38.5 ± 3.3
36.5 ± 4.6 39.4 ± 4.2
38.9 ± 3.8 39.2 ± 3.8
* P < .05 as compared with 0 minute value.
P < .01 as compared with 0 minute value.
‘ P < .001 as compared with 0 minute value.
f P < .05 as compared with the meperidine group.
ft P < .01 as compared with the meperidine group.
ftf P < .001 as compared with the meperidine group.
7.42 ± 0.03
7.38 ± 0.02
7.41 ± 0.01 7.42 ± 0.04
7.38 ± 0.02 7.38 ± 0.03
* P < .05 as compared with 0 minute value.
‘ P < .01 as compared with 0 minute value.
* * * P < .001 as compared with 0 minute value.
f P < .05 as compared with the meperidine group.
tt P < .01 as compared with the meperidine group.
ttf P < .001 as compared with the meperidine group.
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TABLE II
Paco2 In Healthy Volunteers Given Hydroxyzlne and Meperidlne Alone and Their CombInation
Mean ± SD P
Drugs No. 0 mln 5 mln 10 mm
aco2 In mm Hg
20 mln 30 mln 60 mln
Hydroxyzine
(1.5 mg/kg) 29 37.4 ± 3.7 36.1 ± 2.3 35.9 ± 2.4
Meperidine
(1.5 mg/kg) 19 37.6 ± 3.8 39.0 ± 3.2 38.0 ± 4.0
Hydroxyzine
(1.5mg/kg)
and
meperidine
(1.5 mg/kg) 17 36.0 ± 3.5 39.3 ± 47* 41.9 ± 3.8***tt 40.8 ± 2.8***t 39.0 ± 34* 39.3 ± 4.4
tory centers. Contrary to these reports, Lauria et
al.7 in a larger series of geriatric patients could not
observe any depression of ventilation, determined
by CO2 response curves after hydroxyzine IV, and
five of ten subjects had respiratory stimulation
rather than depression. The latter findings corro-
borate our observations on the lack of clinically im-
portant ventilatory depression by blood gas and
spirometric studies in healthy volunteers and in pa-
tients with chronic obstructive lung diseases re-
ported here and earlier in a pilot study.1#{176}
Because we showed previously that arterial blood
gases were unaltered after atropine 0.6 mg IV in
healthy volunteers,16 despite contrary observa-
tions,17 the combination of hydroxyzine 1.5 mg/kg
and atropine 0.008 mg/kg IM can also be used safely
for routine preoperative medication or supplemen-
tation of local or nerve block anesthesia.
In conclusion, hydroxyzine 1.5 mg/kg IM or P0
may be used safely for premedication in place of
analgesics in patients in whom respiratory depres-
sion should be avoided. Blood gas values remained
TABLE Ill
pH In Healthy Volunteers After Hydroxyzlne, Meperidlne, and TheIr CombinatIon
Mean ± SD pH
Drugs No. 0 mln 5 mln 10 mln 20 mln 30 mln 60 mm
Hydroxyzine
(1.5 mg/kg) 29 7.42 ± 0.03 7.42 ± 0.02 7.43 ± 0.03
Meperidine
(1.5 mg/kg) 19 7.39 ± 0.02 7.38 ± 0.03 7.38 ± 0.03
Hydroxyzine
(1.5 mg/kg)
and
meperidine
(1.5 mg/kg) 17 7.41 ± 0.03t 7.38 ± 0.04 7.36 ± 0.02***t 7.36 ± 0.01*ttf 7.40 ± 0.041- 7.40 ± 0.04
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in the normal range after the combined administra-
tion of 1.5 mg/kg of hydroxyzine with the same dose
of meperidine even when given IV instead of IM to
healthy volunteers. Therefore, the combination of
hydroxyzine with meperidine by the IM route in
lower doses than used in this IV study may be used
safely in clinical practice without the hazard of
clinically important ventilatory depression.
We are grateful to all the 65 volunteers, hospital employees,
medical and paramedical personnel for volunteering for these
studies conducted from June 1961 to September 1965 at Alle-
gheny General Hospital, Pittsburgh, Pennsylvania. We greatly ap-
preciate the generous support of Pfizer Laboratories, Inc., Pfizer
Co., which made these studies possible.
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